-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
On September 26, the official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration showed that the clinical application of Amifi Bio-targeted MIF small molecule inhibitor IPG1094 tablets was accepted by the State Food and Drug Administration
Macrophage migration inhibitory factor (MIF) is the only cytokine with enzymatic activity.
MIF inhibitors can not only directly inhibit the growth of tumor cells, but can also reverse the tumor immunosuppressive microenvironment by inhibiting the generation of MDSC, and have dual anti-tumor functions
IPG094 is independently developed by Aimefel Biosciences.